CV2/CRMP5 antibodies

Indication

Suspicion of paraneoplastic syndrome and autoimmune encephalitis.

Method

Immunoblot and indirect immunofluorescence (IIF). For IIF test it is applied a combination of fixed tissues from the nerve, cerebellar, intestinal tissue and pancreas originating from monkeys.

According to guidelines, anti-neuronal antibodies should be detected by at least two independent methods. At Wieslab, IIF and immunoblot are used. According to European guidelines, a positive result should be obtained with both methods to be reliable.

Immunoblot and IIF are accredited analysis for serum samples – read more at the Quality page.

Result

Serum: The result is reported as negative or positive with a titer and blot intensity.

CSF: The result is reported as negative or positive

Interpretation

Antibodies against CV2 is a paraneoplastic marker that is primarily associated with small cell lung cancer, but also occurs with thymoma, and other tumor types. Clinical symptoms may be chorea, sensorimotor neuropathy, limbic encephalitis and cerebellar degeneration. Neurological symptoms may precede the diagnosis of cancer with up to five years.

References

PMID: 15342008; 15258215; 21747075; 22448032 

Read more about sampling

Packages and other tests

View other packages Autoimmune encephalitis (Package 560, 561 and 562). View other tests AMPA receptor 1 and 2 (GluR1 and GluR2) antibodies, Amphiphysin antibodies, CASPR2 antibodies, DPPX (dipeptidyl aminopeptidase-like protein 6) antibodies, GABA B receptor antibodies, GAD antibodies, Hu antibodies, LGI-1 antibodies, Ma (Ma-2/Ta) antibodies, NMDA receptor antibodies, Recoverin antibodies, Ri (Nova 1/ ANNA-2) antibodies, SOX1 antibodies, Titin antibodies, VGKC (voltage gated potassium channel) antibodies, Yo (PCA-1, Purkinje cells antigen 1) antibodies, Zic4 antibodies

Own immunologist